2012
DOI: 10.1097/mlr.0b013e31822dcf15
|View full text |Cite
|
Sign up to set email alerts
|

Comparing VA and Private Sector Healthcare Costs for End-stage Renal Disease

Abstract: Continued research addressing costs and effectiveness of care across public and private sector settings is critical in informing health policy options for patients with complex chronic illnesses such as ESRD.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

4
45
1

Year Published

2013
2013
2019
2019

Publication Types

Select...
6
1
1

Relationship

2
6

Authors

Journals

citations
Cited by 32 publications
(50 citation statements)
references
References 13 publications
4
45
1
Order By: Relevance
“…Using our primary outcome measure, Kidney Disease Quality of Life (KDQOL), we note that typical ESRD patients score about 48.6 points on the KDQOL scale (SD ≈ 11.3). 2,4,29,30 With a goal to raise this figure by 10% to 53.5, which can be clinically meaningful, we calculated power based on a comparison of KDQOL score after 12 months of exposure to the intervention to baseline score (or score at entry for those who entered later). Using SAS macro GEESIZE version 3.1, 26 under a Gaussian GEE model for repeated measures, 77 patients total are required to test this hypothesis with power 0.80 at the alpha = 0.05 two-sided level of significance.…”
Section: Methodsmentioning
confidence: 99%
See 1 more Smart Citation
“…Using our primary outcome measure, Kidney Disease Quality of Life (KDQOL), we note that typical ESRD patients score about 48.6 points on the KDQOL scale (SD ≈ 11.3). 2,4,29,30 With a goal to raise this figure by 10% to 53.5, which can be clinically meaningful, we calculated power based on a comparison of KDQOL score after 12 months of exposure to the intervention to baseline score (or score at entry for those who entered later). Using SAS macro GEESIZE version 3.1, 26 under a Gaussian GEE model for repeated measures, 77 patients total are required to test this hypothesis with power 0.80 at the alpha = 0.05 two-sided level of significance.…”
Section: Methodsmentioning
confidence: 99%
“…1 Despite the relatively low prevalence of ESRD, healthcare expenditures for these patients are disproportionately high, 1, 2 and individuals experience high morbidity, mortality, and poor quality of life (QOL). 1,3,4,5,6 In 2012, Medicare expenditures for ESRD totaled $28.6 billion.…”
Section: Introductionmentioning
confidence: 99%
“…37 Four studies examined equity, with one study showing better performance on several chronic disease and preventive measures, 51 one study showing worse performance in VA facilities for emergency room visits among cancer patients in the last month of life, 76 and two studies showing similar equity in 30-day post-admission mortality 78 and graft failure. 27 Nine articles compared efficiency using utilization, with six studies showing worse performance in VA facilities on outcomes such as average length of stay and service utilization for patients on dialysis, 32,61,[79][80][81][82] two showing better performance for visits/ admissions 83 and generic drug utilization, 84 and one with mixed results for utilization-related inpatient quality indicators. Five studies examined patient-centeredness; three studies demonstrated better patient and family satisfaction in VA facilities 77,85,86 and two demonstrated similar performance in perceptions of racial discrimination and satisfaction in transitional programs for homeless veterans.…”
Section: Safetymentioning
confidence: 99%
“…Prior work has examined utilization and outcomes of renal care in VA and Medicare systems [4,6], but less is known about the VA’s own organization of in- and out-of-network chronic dialysis treatment services. VA-outsourced dialysis is a major contributor to increasing ESRD costs for the VA.…”
Section: Introductionmentioning
confidence: 99%